| |
> Return to News Page |
Cardinal Health Debuts Medical Imaging and Therapy
Quality Assurance Catalog
CLEVELAND, Ohio (July 10, 2003) — Cardinal Health
Inc. (NYSE: CAH), the leading provider of products and services supporting
the health care industry, today announced that distribution of their new
2004 Medical Imaging and Therapy Quality Assurance Catalog is now available
through its Radiation Management Services business. Organized with technical
descriptions and application notes, the 400-page, full-color catalog serves
as a quality assurance reference book for all medical imaging applications.
“At Cardinal Health, we believe that better patient care begins
with improved radiation protection,” said Susan Janney, Director,
Product Development. “Our customers have a growing need to record,
verify, trend and archive radiation dose information. This comprehensive
catalog contains the total solution for managing radiation in today’s
healthcare environment and enables our customers to focus on what matters
most – improving patient care.”
Well-known brands of Victoreen® and Nuclear Associates, and Cardinal
Health’s highly-accredited Global Calibration Laboratory, which
offers a one-stop service and calibration for instruments, are featured
in the catalog. The Medical Imaging & Therapy Quality Assurance Catalog
effectively delivers quality assurance solutions in the diagnostic imaging,
radiation oncology and health/medical physics areas.
About Radiation Management Services
As part of Nuclear Pharmacy Services, the Radiation Management Services
business of Cardinal Health is an industry leader in providing solutions
for maintaining a safe, regulatory-compliant practice in medical and therapeutic
imaging facilities. The company develops and distributes radiation detection
instruments, accessories, supplies and information management software
to more than 50,000 customers worldwide.
About Cardinal Health
Cardinal Health, Inc. (www.cardinal.com)
is the leading provider of products and services supporting the health
care industry. Cardinal Health companies develop, manufacture, package
and market products for patient care; develop drug-delivery technologies;
distribute pharmaceuticals, medical-surgical and laboratory supplies;
and offer consulting and other services that improve quality and efficiency
in healthcare. Headquartered in Dublin, Ohio, Cardinal Health employs
more than 50,000 people on five continents and produces annual revenues
of more than $47 billion. Cardinal Health is ranked #19 on the current
Fortune 500 list and was named one of “The World’s Best”
companies by Forbes magazine in 2002.
Except for historical information, all other information in this news
release consists of forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. These forward-looking
statements are subject to risks and uncertainties that could cause actual
results to differ materially from those projected, anticipated or implied.
The most significant of these uncertainties are described in Cardinal
Health's Form 10-K, Form 8-K and Form 10-Q reports (including all amendments
to those reports) and exhibits to those reports, and include (but are
not limited to) the costs, difficulties, and uncertainties related to
the integration of acquired businesses, the loss of one or more key customer
or supplier relationships, changes in the distribution patterns or reimbursement
rates for health-care products and/or services, the costs and other effects
of governmental regulation and legal and administrative proceedings, and
general economic and market conditions. Cardinal Health undertakes no
obligation to update or revise any forward-looking statements.
> Return to News Page
|
|
